Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37209222)

  • 1. Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study.
    Rijken A; van de Vlasakker VCJ; Simkens GA; Rovers KP; van Erning FN; Koopman M; Verhoef C; de Wilt JHW; de Hingh IHJT
    Clin Exp Metastasis; 2023 Aug; 40(4):289-298. PubMed ID: 37209222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases.
    Rovers KP; Bakkers C; van Erning FN; Burger JWA; Nienhuijs SW; Simkens GAAM; Creemers GM; Hemmer PHJ; Punt CJA; Lemmens VEPP; Tanis PJ; de Hingh IHJT
    JAMA Oncol; 2020 Aug; 6(8):e202701. PubMed ID: 32672798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.
    't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH
    Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Hingh IH; Creemers GJ
    Clin Colorectal Cancer; 2016 Jun; 15(2):e41-6. PubMed ID: 26762572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study.
    Bakkers C; van der Meer R; Roumen RM; Lurvink RJ; Lemmens VE; van Erning FN; de Hingh IH
    Int J Colorectal Dis; 2020 Jun; 35(6):1035-1044. PubMed ID: 32157379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
    Kunitomo A; Ouchi A; Komori K; Kinoshita T; Sato Y; Abe T; Ito S; Sano T; Shimizu Y
    Ann Surg Oncol; 2023 Dec; 30(13):8501-8508. PubMed ID: 37658266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative surgery for colorectal cancer with peritoneal metastasis: a propensity-score matching analysis.
    Jeong SJ; Yoon YS; Lee JB; Lee JL; Kim CW; Park IJ; Lim SB; Yu CS; Kim JC
    Surg Today; 2017 Feb; 47(2):159-165. PubMed ID: 27549772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.
    Lurvink RJ; Rijken A; Bakkers C; Lemmens VE; de Reuver PR; Tuynman JB; Kok NF; Nienhuijs SW; van Erning FN; de Hingh IHJT
    Surg Endosc; 2022 Sep; 36(9):6551-6557. PubMed ID: 35059835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
    Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ;
    BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
    Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
    Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern-day palliative chemotherapy for metastatic colorectal cancer: does colonic resection affect survival?
    Lau JWL; Chang HSY; Lee KY; Gwee YX; Lee WQ; Chong CS
    ANZ J Surg; 2018 Nov; 88(11):E772-E777. PubMed ID: 29938886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
    Klaver YL; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Shida D; Tsukamoto S; Ochiai H; Kanemitsu Y
    Ann Surg Oncol; 2018 Jan; 25(1):173-178. PubMed ID: 29063295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    Stelzner S; Radulova-Mauersberger O; Zschuppe E; Kittner T; Abolmaali N; Puffer E; Zimmer J; Witzigmann H
    J Surg Oncol; 2019 Sep; 120(3):438-445. PubMed ID: 31168858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis.
    Chen X; Hu W; Huang C; Liang W; Zhang J; Wu D; Lv Z; Li Y; Luo Y; Liang Z; Wang M; Wang J; Yao X
    Int J Surg; 2020 Aug; 80():135-152. PubMed ID: 32634480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
    Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment?
    Pinto A; Hobeika C; Philis A; Kirzin S; Carrère N; Ghouti L
    Langenbecks Arch Surg; 2019 Jun; 404(4):477-488. PubMed ID: 31025165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.
    Yun JA; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Dis Colon Rectum; 2014 Sep; 57(9):1049-58. PubMed ID: 25101600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
    Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
    J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.